Saenz, D T
Fiskus, W
Qian, Y
Manshouri, T
Rajapakshe, K
Raina, K
Coleman, K G
Crew, A P
Shen, A
Mill, C P
Sun, B
Qiu, P
Kadia, T M
Pemmaraju, N
DiNardo, C
Kim, M-S
Nowak, A J
Coarfa, C
Crews, C M
Verstovsek, S
Bhalla, K N
Article History
Received: 19 September 2016
Revised: 21 November 2016
Accepted: 5 December 2016
First Online: 2 February 2017
Competing interests
: CMC is the founder and Chief Scientific Advisor of, and possesses an equity ownership stake in, Arvinas, LLC. YQ, KR, KGC, APC and AS are Arvinas employees and possess an equity ownership stake in Arvinas. NP serves on the scientific advisory board of Incyte Pharmaceuticals. He has also served as a consultant and received research funding from Novartis Pharmaceuticals. The remaining authors declare no conflict of interest.